Mianserin Viatris

Mianserin, the active ingredient in Mianserin Viatris, is a tetracyclic antidepressant presented as an oral dosage form for oral use. It is indicated for the treatment of major depressive disorder in adult patients. GNH USA supplies Mianserin Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mianserin is a tetracyclic antidepressant used primarily in the management of depressive disorders. - Major depressive disorder: alleviates depressive symptoms and improves mood in adults. - Treatment‑resistant depression: may be added when first‑line agents are insufficient. - Adjunctive therapy for anxiety associated with depression: helps reduce anxiety symptoms alongside mood improvement.

Mianserin may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to a parched sensation. - Weight gain: increase in body weight over time. - Constipation: difficulty passing stools. - Dizziness: sensation of light‑headedness or unsteadiness. - Increased appetite: heightened desire for food.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells. - Seizures: convulsive episodes, especially at high doses. - Severe hypotension: marked drop in blood pressure causing faintness. - Cardiac arrhythmia: irregular heart rhythm. - Suicidal thoughts: emergence or worsening of suicidal ideation. - Hepatic dysfunction: abnormal liver enzyme elevations or liver injury.

Before initiating therapy with Mianserin, several safety considerations should be observed. - Blood pressure monitoring: watch for hypotension, especially after dose changes. - Suicidal risk assessment: evaluate for suicidal thoughts, particularly in early treatment. - Elderly use: start low and increase slowly to reduce fall risk. - Discontinuation: avoid abrupt cessation to prevent withdrawal symptoms. - Hepatic/renal function: adjust dosing if liver or kidney impairment is present. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Mianserin can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Selective serotonin reuptake inhibitors (SSRIs): increased serotonin syndrome risk. - Tricyclic antidepressants (TCAs): additive cardiotoxic effects.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Antihypertensive agents: potential for exaggerated blood pressure lowering. - CYP2D6 inhibitors: may raise Mianserin plasma concentrations.